These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23588800)

  • 1. Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
    Erren TC; Reiter RJ
    Int J Cancer; 2013 Oct; 133(8):2010-1. PubMed ID: 23588800
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's reply to: Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
    Wu AH; Yu MC
    Int J Cancer; 2013 Oct; 133(8):2012. PubMed ID: 23588716
    [No Abstract]   [Full Text] [Related]  

  • 3. Sleep duration, melatonin and breast cancer among Chinese women in Singapore.
    Wu AH; Wang R; Koh WP; Stanczyk FZ; Lee HP; Yu MC
    Carcinogenesis; 2008 Jun; 29(6):1244-8. PubMed ID: 18448486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
    Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
    Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sleep and breast cancer: is there a link?].
    Malina C; Frigo S; Mathelin C
    Gynecol Obstet Fertil; 2013 Feb; 41(2):105-9. PubMed ID: 23395427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light exposure at night, sleep duration, melatonin, and breast cancer: a dose-response analysis of observational studies.
    Yang WS; Deng Q; Fan WY; Wang WY; Wang X
    Eur J Cancer Prev; 2014 Jul; 23(4):269-76. PubMed ID: 24858716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of exercise on urinary 6-sulfatoxymelatonin and catecholamines in young women participating in a 16-week randomized controlled trial.
    Arikawa AY; Thomas W; Patel SR; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1634-6. PubMed ID: 23861293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
    Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
    Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women.
    Nagata C; Matsubara T; Hara T; Fujita H; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2509-12. PubMed ID: 18006946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Melatonin and breast cancer: a prospective study.
    Hrushesky WJ; Blask DE
    J Natl Cancer Inst; 2004 Jun; 96(11):888-9. PubMed ID: 15173281
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
    Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep disturbances and changes in urinary 6-sulphatoxymelatonin levels in patients with breast cancer undergoing lumpectomy.
    Hansen MV; Madsen MT; Wildschiødtz G; Rosenberg J; Gögenur I
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1146-53. PubMed ID: 23848183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses.
    Grundy A; Sanchez M; Richardson H; Tranmer J; Borugian M; Graham CH; Aronson KJ
    Chronobiol Int; 2009 Oct; 26(7):1443-61. PubMed ID: 19916841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repercussions of melatonin on the risk of breast cancer: a systematic review and meta-analysis.
    Veiga ECA; Simões R; Valenti VE; Cipolla-Neto J; Abreu LC; Barros EPM; Sorpreso ICE; Baracat MCP; Baracat EC; Soares Junior JM
    Rev Assoc Med Bras (1992); 2019 Jun; 65(5):699-705. PubMed ID: 31166448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of melatonin.
    Wetterberg L
    Prog Brain Res; 1979; 52():539-47. PubMed ID: 549099
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
    Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
    [No Abstract]   [Full Text] [Related]  

  • 18. Sleep duration, nightshift work, and the timing of meals and urinary levels of 8-isoprostane and 6-sulfatoxymelatonin in Japanese women.
    Nagata C; Tamura T; Wada K; Konishi K; Goto Y; Nagao Y; Ishihara K; Yamamoto S
    Chronobiol Int; 2017; 34(9):1187-1196. PubMed ID: 28933565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials.
    Kunz D; Mahlberg R; Müller C; Tilmann A; Bes F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):128-34. PubMed ID: 14715839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal associations between endogenous melatonin production and reported sleep duration from childhood to early adulthood.
    Diethelm K; Libuda L; Bolzenius K; Griefahn B; Buyken AE; Remer T
    Horm Res Paediatr; 2010; 74(6):390-8. PubMed ID: 20516653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.